Enlivex Therapeutics

-$0.04 (-0.98%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENLV and other ETFs, options, and stocks.

About ENLV

Enlivex Therapeutics Ltd. is a clinical stage macrophage reprogramming immunotherapy company, which develops Allocetra,a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded on January 22, 2012 and is headquartered in Nes-Ziona, Israel.

CEO
Oren Hershkovitz
Employees
71
Headquarters
Nes-Ziona, Tel Aviv
Founded
2012

ENLV Key Statistics

Market cap
74.04M
Price-Earnings ratio
—
Dividend yield
—
Average volume
67.36K
High today
$4.10
Low today
$3.92
Open price
$4.05
Volume
35.79K
52 Week high
$13.95
52 Week low
$3.65

ENLV Earnings

-$0.27
-$0.18
-$0.09
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected May 27, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure